- Home
- VCEL vs HAPN Comparison
VCEL vs HAPN Comparison
Compare VCEL & HAPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$46.85
Company Overview
Basic Information| Metric | VCEL | HAPN |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCEL | HAPN |
|---|---|---|
| Price | $46.85 | $19.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $57.75 | N/A |
| AVG Volume (30 Days) | 704.3K | ★ 1.7M |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.40 | N/A |
| Revenue Next Year | $18.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $18.58 |
| 52 Week High | $48.75 | $21.21 |
Technical Indicators
Market Signals| Indicator | VCEL | HAPN |
|---|---|---|
| Relative Strength Index (RSI) | 62.66 | 39.53 |
| Support Level | $32.47 | $18.58 |
| Resistance Level | N/A | $20.66 |
| Average True Range (ATR) | 1.76 | 0.79 |
| MACD | -0.21 | -0.05 |
| Stochastic Oscillator | 61.88 | 24.33 |
Price Performance
Historical Comparison VCEL
HAPN
About VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.